Drug intelligence / Profile preview

ENERGI-F705

Development stage
Phase 2
Lead developer
Energenesis Biomedical
Modality
Small Molecules
Administration
Oral
01

Overview

ENERGI-F705 is a small molecule drug developed by Energenesis Biomedical. It acts as an agonist of AMP-activated protein kinase (AMPK), stimulating this enzyme to exert therapeutic effects. The drug is being investigated primarily for the treatment of Parkinson's disease, with additional preclinical research in metabolic, neurodegenerative, mitochondrial, and skin disorders. Its mechanism involves activation of AMPK, which plays a key role in cellular energy homeostasis and may have anti-inflammatory and neuroprotective effects. As of early 2025, it has entered phase 1 clinical trials as an oral medication for Parkinson's disease[1][2][3][7].

Brand names
ENERGI-F705PDENERGI-F-705PDENERGI-F 705PD
Other names
ENERGI-F705PDENERGI-F-705PDENERGI-F 705PD
02

Targets

AMPK (Adenosine monophosphate–activated protein kinase)

Beyond the preview

Go deeper on ENERGI-F705.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ENERGI-F705.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call